Literature DB >> 30904501

Ultrasound-activated microbubbles as a novel intracellular drug delivery system for urinary tract infection.

H Horsley1, J Owen2, R Browning2, D Carugo3, J Malone-Lee1, E Stride2, J L Rohn4.   

Abstract

The development of new modalities for high-efficiency intracellular drug delivery is a priority for a number of disease areas. One such area is urinary tract infection (UTI), which is one of the most common infectious diseases globally and which imposes an immense economic and healthcare burden. Common uropathogenic bacteria have been shown to invade the urothelial wall during acute UTI, forming latent intracellular reservoirs that can evade antimicrobials and the immune response. This behaviour likely facilitates the high recurrence rates after oral antibiotic treatments, which are not able to penetrate the bladder wall and accumulate to an effective concentration. Meanwhile, oral antibiotics may also exacerbate antimicrobial resistance and cause systemic side effects. Using a human urothelial organoid model, we tested the ability of novel ultrasound-activated lipid microbubbles to deliver drugs into the cytoplasm of apical cells. The gas-filled lipid microbubbles were decorated with liposomes containing the non-cell-permeant antibiotic gentamicin and a fluorescent marker. The microbubble suspension was added to buffer at the apical surface of the bladder model before being exposed to ultrasound (1.1 MHz, 2.5 Mpa, 5500 cycles at 20 ms pulse duration) for 20 s. Our results show that ultrasound-activated intracellular delivery using microbubbles was over 16 times greater than the control group and twice that achieved by liposomes that were not associated with microbubbles. Moreover, no cell damage was detected. Together, our data show that ultrasound-activated microbubbles can safely deliver high concentrations of drugs into urothelial cells, and have the potential to be a more efficacious alternative to traditional oral antibiotic regimes for UTI. This modality of intracellular drug delivery may prove useful in other clinical indications, such as cancer and gene therapy, where such penetration would aid in treatment.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antimicrobial resistance; Cavitation; Chronic infection; Drug delivery; Encapsulation; Intelligent delivery; Intracellular infection; Microbubbles; Sonoporation; Ultrasound

Year:  2019        PMID: 30904501     DOI: 10.1016/j.jconrel.2019.03.017

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  14 in total

Review 1.  Ultrasonic technologies in imaging and drug delivery.

Authors:  Yi-Ju Ho; Chih-Chung Huang; Ching-Hsiang Fan; Hao-Li Liu; Chih-Kuang Yeh
Journal:  Cell Mol Life Sci       Date:  2021-07-23       Impact factor: 9.261

Review 2.  Sonobactericide: An Emerging Treatment Strategy for Bacterial Infections.

Authors:  Kirby R Lattwein; Himanshu Shekhar; Joop J P Kouijzer; Willem J B van Wamel; Christy K Holland; Klazina Kooiman
Journal:  Ultrasound Med Biol       Date:  2019-11-05       Impact factor: 3.694

Review 3.  Ultrasound-Responsive Cavitation Nuclei for Therapy and Drug Delivery.

Authors:  Klazina Kooiman; Silke Roovers; Simone A G Langeveld; Robert T Kleven; Heleen Dewitte; Meaghan A O'Reilly; Jean-Michel Escoffre; Ayache Bouakaz; Martin D Verweij; Kullervo Hynynen; Ine Lentacker; Eleanor Stride; Christy K Holland
Journal:  Ultrasound Med Biol       Date:  2020-03-10       Impact factor: 2.998

4.  Ultrasound Assisted a Peroxisome Proliferator-Activated Receptor (PPAR)γ Agonist-Loaded Nanoparticle-Microbubble Complex to Attenuate Renal Interstitial Fibrosis.

Authors:  Shuping Wei; Chaoli Xu; Yidan Zhang; Zhongqing Shi; Min Wu; Bin Yang
Journal:  Int J Nanomedicine       Date:  2020-10-02

Review 5.  Interactions of plasma-activated water with biofilms: inactivation, dispersal effects and mechanisms of action.

Authors:  Anne Mai-Prochnow; Renwu Zhou; Tianqi Zhang; Kostya Ken Ostrikov; Sudarsan Mugunthan; Scott A Rice; Patrick J Cullen
Journal:  NPJ Biofilms Microbiomes       Date:  2021-01-27       Impact factor: 7.290

6.  Meta-Analysis of Drug Delivery Approaches for Treating Intracellular Infections.

Authors:  Sooyoung Shin; Soonbum Kwon; Yoon Yeo
Journal:  Pharm Res       Date:  2022-02-10       Impact factor: 4.200

7.  Safety Assessment of Ultrasound-Assisted Intravesical Chemotherapy in Normal Dogs: A Pilot Study.

Authors:  Noboru Sasaki; Yoshinori Ikenaka; Keisuke Aoshima; Teiichiro Aoyagi; Nobuki Kudo; Kensuke Nakamura; Mitsuyoshi Takiguchi
Journal:  Front Pharmacol       Date:  2022-03-18       Impact factor: 5.810

Review 8.  Ultrasound-mediated therapies for the treatment of biofilms in chronic wounds: a review of present knowledge.

Authors:  Gareth LuTheryn; Peter Glynne-Jones; Jeremy S Webb; Dario Carugo
Journal:  Microb Biotechnol       Date:  2019-08-07       Impact factor: 5.813

9.  Non-Cavitation Targeted Microbubble-Mediated Single-Cell Sonoporation.

Authors:  Xiufang Liu; Wenjun Zhang; Yanshu Jing; Shasha Yi; Umar Farooq; Jingyao Shi; Na Pang; Ning Rong; Lisheng Xu
Journal:  Micromachines (Basel)       Date:  2022-01-11       Impact factor: 2.891

10.  Ultrasound Triggered Drug Release from Affinity-Based β-Cyclodextrin Polymers for Infection Control.

Authors:  Smriti Bohara; Nathan Rohner; Emily Budziszewski; Jackrit Suthakorn; Horst A von Recum; Agata A Exner
Journal:  Ann Biomed Eng       Date:  2021-06-25       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.